539787 Panoramica delle azioni HealthCare Global Enterprises Limited, insieme alle sue controllate, fornisce servizi medici e sanitari incentrati sul cancro e sulla fertilità in India e a livello internazionale. Maggiori dettagli
Premi Analisi del rischio Vedi tutti gli assegni di rischio Catturate i vostri pensieri, i link e la narrativa aziendale
Aggiungi notaHealthCare Global Enterprises Limited Concorrenti Storia dei prezzi e prestazioni
Riepilogo dei massimi, dei minimi e delle variazioni dei prezzi delle azioni per HealthCare Global Enterprises Prezzi storici delle azioni Prezzo attuale dell'azione ₹484.90 Massimo di 52 settimane ₹553.25 Minimo di 52 settimane ₹310.10 Beta 0.29 Variazione di 1 mese -4.87% Variazione a 3 mesi 12.77% Variazione di 1 anno 32.14% Variazione a 3 anni 102.46% Variazione a 5 anni 364.24% Variazione dall'IPO 183.65%
Notizie e aggiornamenti recenti
KKR Reportedly Close to Buying HCG Dec 05
Price target increased by 9.0% to ₹473 Nov 13
Second quarter 2025 earnings: EPS misses analyst expectations Nov 12
HealthCare Global Enterprises Limited Announces the Resignation of Mr. Jeyandran Venugopal as from the Board and Member of Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Board Nov 09
HealthCare Global Enterprises Limited to Report Q2, 2025 Results on Nov 09, 2024 Oct 24
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of 51% stake in Vizag Hospital and Cancer Research Centre Private Limited. Oct 03 Vedi altri aggiornamenti
KKR Reportedly Close to Buying HCG Dec 05
Price target increased by 9.0% to ₹473 Nov 13
Second quarter 2025 earnings: EPS misses analyst expectations Nov 12
HealthCare Global Enterprises Limited Announces the Resignation of Mr. Jeyandran Venugopal as from the Board and Member of Nomination and Remuneration Committee and Corporate Social Responsibility Committee of the Board Nov 09
HealthCare Global Enterprises Limited to Report Q2, 2025 Results on Nov 09, 2024 Oct 24
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of 51% stake in Vizag Hospital and Cancer Research Centre Private Limited. Oct 03 HealthCare Global Enterprises Limited, Annual General Meeting, Sep 25, 2024 Sep 03
First quarter 2025 earnings released: EPS: ₹0.87 (vs ₹0.55 in 1Q 2024) Aug 09
HealthCare Global Enterprises Limited to Report Q1, 2025 Results on Aug 08, 2024 Jul 25
HealthCare Global Enterprises Limited (NSEI:HCG) entered into share purchase agreement to acquire 51% stake in Vizag Hospital and Cancer Research Centre Private Limited for INR 2.1 billion. Jun 28
HealthCare Global Enterprises Limited to Report Q4, 2024 Results on May 29, 2024 May 17
Temasek May Bid for CVC's 60% Stake in Healthcare Global May 04
EQT, TPG and KKR Reportedly Eye Majority Stake in HCG Feb 20
New major risk - Financial position Feb 11
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Feb 09
HealthCare Global Enterprises Limited to Report Q3, 2024 Results on Feb 08, 2024 Jan 18
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 10
HealthCare Global Enterprises Limited to Report Q2, 2024 Results on Nov 09, 2023 Oct 28
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of Radiation Business from Amrish Oncology Services Private Limited. Oct 06
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of Oncology Business from SRJ Health Care Private Limited. Oct 05 CVC Capital Mulls Selling Stake in HealthCare Global Enterprises Sep 27
HealthCare Global Enterprises Limited, Annual General Meeting, Sep 20, 2023 Aug 30
HealthCare Global Enterprises Limited (NSEI:HCG) completed the acquisition of Nagpur Cancer Hospital & Research Institute Private Limited from Ajay Mehta, Suchitra Mehta and other shareholders. Aug 23 HealthCare Global Enterprises Limited Announces CFO Changes Aug 19
New major risk - Financial position Aug 12 HealthCare Global Enterprises Limited (NSEI:HCG) executed business transfer agreement to acquire Radiation Business from Amrish Oncology Services Private Limited for INR 160 million.
First quarter 2024 earnings: EPS misses analyst expectations Aug 11
HealthCare Global Enterprises Limited to Report Q1, 2024 Results on Aug 10, 2023 Jul 29 HealthCare Global Enterprises Limited (NSEI:HCG) entered into a share purchase agreement to acquire Nagpur Cancer Hospital & Research Institute Private Limited from Ajay Mehta, Suchitra Mehta and other shareholders for approximately INR 140 million. Jul 07
Executive Chairman recently sold ₹1.1b worth of stock Jun 04
Full year 2023 earnings: EPS misses analyst expectations May 30
Full year 2023 earnings: EPS misses analyst expectations May 30
HealthCare Global Enterprises Limited to Report Q4, 2023 Results on May 25, 2023 May 13
Insider recently sold ₹794k worth of stock Apr 02
Insider recently sold ₹1.7m worth of stock Mar 15
Insider recently sold ₹2.9m worth of stock Feb 24
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Feb 10
HealthCare Global Enterprises Limited to Report Q3, 2023 Results on Feb 09, 2023 Jan 25
Insider recently sold ₹846k worth of stock Jan 01
Insider recently sold ₹332k worth of stock Dec 07
Second quarter 2023 earnings released: EPS: ₹0.53 (vs ₹8.22 in 2Q 2022) Nov 16
High number of new and inexperienced directors Nov 16
Second quarter 2023 earnings released: EPS: ₹0.53 (vs ₹8.22 in 2Q 2022) Nov 13
HealthCare Global Enterprises Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 01
HealthCare Global Enterprises Limited, Annual General Meeting, Sep 29, 2022 Sep 08
HealthCare Global Enterprises Limited, Annual General Meeting, Sep 29, 2022 Sep 07
Price target decreased to ₹350 Aug 20
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 11
HealthCare Global Enterprises Limited to Report Q1, 2023 Results on Aug 10, 2022 Jul 29
Executive Chairman recently sold ₹500m worth of stock Jul 04
HealthCare Global Enterprises Limited (BSE:539787) agreed to acquire Radiation therapy centre of Radiant Hospital Services Private Limited from Radiant Hospitality Services Private Limited for INR 160 million. Jun 24
Consensus EPS estimates fall by 23% Jun 04
Price target increased to ₹377 May 30
Full year 2022 earnings: EPS exceeds analyst expectations May 29
Price target increased to ₹293 May 20
HealthCare Global Enterprises Limited to Report Fiscal Year 2022 Results on May 26, 2022 May 14
High number of new and inexperienced directors Apr 27
Insider recently sold ₹719k worth of stock Mar 10
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 13
Healthcare Global Enterprises Limited Announces Board Appointments Feb 11
Non-Executive Independent Director Shanker Annaswamy has left the company Dec 05
Price target increased to ₹266 Nov 23
Second quarter 2022 earnings released: EPS ₹8.22 (vs ₹1.94 loss in 2Q 2021) Nov 15
Insider recently sold ₹1.2m worth of stock Sep 23 HealthCare Global Enterprises Limited (BSE:539787) agreed to acquire Hospital Lab Management and Clinical Research Site Management units of Strand Life Sciences.
First quarter 2022 earnings released: ₹0.76 loss per share (vs ₹4.48 loss in 1Q 2021) Aug 13
High number of new directors Aug 01
Consensus EPS estimates increase to -₹1.30 Jun 25
Price target increased to ₹196 Jun 21
Full year 2021 earnings released: ₹17.02 loss per share (vs ₹12.05 loss in FY 2020) Jun 20
Non-Executive Independent Director Bhushani Kumar has left the company Jun 04
Non- Independent Non-Executive Director has left the company Apr 04
Executive Chairman recently bought ₹2.4m worth of stock Mar 14
New 90-day high: ₹178 Mar 08
Earnings beat expectations, revenue disappoints Feb 14
Third quarter 2021 earnings released: ₹2.33 loss per share (vs ₹2.57 loss in 3Q 2020) Feb 14
HealthCare Global Enterprises Limited Announces Board Changes Feb 13
Price target raised to ₹166 Feb 12 Healthcare Global Enterprises Limited Announces Chief Executive Officer Changes
Healthcare Global Enterprises Limited Announces Executive Changes Jan 01
New 90-day high: ₹156 Dec 09
Price target raised to ₹155 Dec 01
HealthCare Global Enterprises Limited (BSE:539787) completed the acquisition of remaining 49.9% stake in BACC HealthCare Private Limited from Kamini A. Rao for approximately INR 680 million. Nov 29
HealthCare Global Enterprises Limited Appoints Meghraj Arvindrao Gore as the CEO and KMP, Effective on February 01, 2021 Nov 28
New 90-day high: ₹132 Nov 20
Analysts update estimates Nov 14
HealthCare Global Enterprises Limited to Report Q2, 2021 Results on Nov 12, 2020 Nov 04
New 90-day low - ₹116 Sep 09
Analysts update estimates Aug 27
First quarter earnings released Aug 21
HealthCare Global Enterprises Limited to Report Q1, 2021 Results on Aug 20, 2020 Aug 13
New 90-day high - ₹127 Aug 03 Rendimenti per gli azionisti 539787 IN Healthcare IN Mercato 7D 2.6% 2.0% 1.8% 1Y 32.1% 37.3% 18.0%
Vedi i rendimenti completi degli azionisti
Ritorno vs Industria: 539787 ha avuto una performance inferiore rispetto al Indian Healthcare che ha registrato un rendimento 37.3 % nell'ultimo anno.
Rendimento vs Mercato: 539787 ha superato il mercato Indian che ha restituito 18 % nell'ultimo anno.
Volatilità dei prezzi Is 539787's price volatile compared to industry and market? 539787 volatility 539787 Average Weekly Movement 5.3% Healthcare Industry Average Movement 5.2% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Prezzo delle azioni stabile: 539787 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.
Volatilità nel tempo: La volatilità settimanale ( 5% ) di 539787 è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda HealthCare Global Enterprises Limited, insieme alle sue controllate, fornisce servizi medici e sanitari incentrati sul cancro e sulla fertilità in India e a livello internazionale. L'azienda offre servizi di diagnosi e trattamento del cancro attraverso la radioterapia, l'oncologia medica e la chirurgia; e servizi di trattamento della fertilità, tra cui medicina riproduttiva, riproduzione assistita, endoscopia ginecologica e conservazione della fertilità con il marchio Milann. L'azienda gestisce anche ospedali multispecialistici con il marchio HCG, che fornisce trattamenti ospedalieri e ambulatoriali con specialità in cardiologia, neurologia, ortopedia, gastroenterologia, urologia, medicina interna e polmonare e cure critiche.
Mostra di più HealthCare Global Enterprises Limited Riepilogo dei fondamenti Come si confrontano gli utili e i ricavi di HealthCare Global Enterprises con la sua capitalizzazione di mercato? 539787 statistiche fondamentali Capitalizzazione di mercato ₹67.49b Guadagni(TTM ) ₹570.45m Ricavi(TTM ) ₹20.44b
Guadagni e ricavi Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM) 539787 Conto economico (TTM ) Ricavi ₹20.44b Costo del fatturato ₹9.46b Profitto lordo ₹10.98b Altre spese ₹10.41b Guadagni ₹570.45m
Ultimi guadagni dichiarati
Sep 30, 2024
Prossima data di guadagno
n/a
Utile per azione (EPS) 4.09 Margine lordo 53.71% Margine di profitto netto 2.79% Rapporto debito/patrimonio netto 82.8%
Come si è comportato 539787 nel lungo periodo?
Vedi performance storica e confronto
Analisi aziendale e situazione dei dati finanziari Dati Ultimo aggiornamento (ora UTC) Analisi dell'azienda 2025/01/02 09:05 Prezzo dell'azione a fine giornata 2025/01/02 00:00 Guadagni 2024/09/30 Guadagni annuali 2024/03/31
Fonti dei dati I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC . I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
Pacchetto Dati Tempistica Esempio Fonte USA * Dati finanziari della società 10 anni Conto economico Rendiconto finanziario Bilancio Stime di consenso degli analisti +3 anni Previsioni finanziarie Obiettivi di prezzo degli analisti Prezzi di mercato 30 anni Prezzi delle azioni Dividendi, scissioni e azioni Proprietà 10 anni Top azionisti Insider trading Gestione 10 anni Team di leadership Consiglio di amministrazione Sviluppi principali 10 anni
* esempio per i titoli statunitensi, per quelli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più , cliccate qui .
Modello di analisi e Snowflake I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github ; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube .
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su .
Fonti analitiche HealthCare Global Enterprises Limited è coperta da 20 analisti. 9 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
Analista Istituzione Candice Pereira Anand Rathi Shares and Stock Brokers Limited Kripashankar Maurya Choice Equity Broking Private Limited Deepika Murarka Choice Equity Broking Private Limited
Mostra 17 altri analisti